These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2454383)

  • 1. Metabolic correlates and axonal transport in nerves during experimental diabetes.
    Alberghina M
    Metab Pediatr Syst Ophthalmol (1985); 1986; 9(2-4):42-6. PubMed ID: 2454383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral nerve biochemistry in diabetes.
    Clements RS
    Clin Physiol; 1985; 5 Suppl 5():19-22. PubMed ID: 2421965
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy.
    Shindo H; Tawata M; Aida K; Onaya T
    J Clin Endocrinol Metab; 1992 Feb; 74(2):393-8. PubMed ID: 1370506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyols and myo-inositol in diabetic neuropathy--of mice and men.
    Tomlinson DR
    Mayo Clin Proc; 1989 Aug; 64(8):1030-3. PubMed ID: 2796398
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathogenesis of diabetic neuropathy: role of altered phosphoinositide metabolism.
    Greene DA; Lattimer-Greene S; Sima AA
    Crit Rev Neurobiol; 1989; 5(2):143-219. PubMed ID: 2561904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alterations in the sorbitol pathway and Na(+)-K(+)-ATPase activity of peripheral nerve of alloxan-induced diabetic rats].
    Lu KM; Zhong XL; Zhu XX; Zhu QY
    Sheng Li Xue Bao; 1990 Aug; 42(4):401-5. PubMed ID: 2175949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered sorbitol and myo-inositol metabolism as the basis for defective protein kinase C and (Na,K)-ATPase regulation in diabetic neuropathy.
    Greene DA; Lattimer SA
    Ann N Y Acad Sci; 1986; 488():334-40. PubMed ID: 3034118
    [No Abstract]   [Full Text] [Related]  

  • 8. Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry.
    Dyck PJ; Sherman WR; Hallcher LM; Service FJ; O'Brien PC; Grina LA; Palumbo PJ; Swanson CJ
    Ann Neurol; 1980 Dec; 8(6):590-6. PubMed ID: 7212646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axonal transport and nerve conduction and their relation to nerve polyol and myo-inositol levels in spontaneously diabetic BB/D rats.
    Mayer JH; Herberg L; Tomlinson DR
    Neurochem Pathol; 1984-1985 Winter; 2(4):285-93. PubMed ID: 6085698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathogenesis of diabetic neuropathies].
    Lalau JD; Arlot S; Quichaud J
    Ann Med Interne (Paris); 1985; 136(6):486-95. PubMed ID: 3909874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sorbitol pathway: presence in nerve and cord with substrate accumulation in diabetes.
    Gabbay KH; Merola LO; Field RA
    Science; 1966 Jan; 151(3707):209-10. PubMed ID: 5907911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a sorbitol dehydrogenase inhibitor on diabetic peripheral nerve metabolism: a prevention study.
    Obrosova IG; Fathallah L; Lang HJ; Greene DA
    Diabetologia; 1999 Oct; 42(10):1187-94. PubMed ID: 10525658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased incorporation of [3H]inositol and [3H]glycerol into glycerolipids of sciatic nerve from the streptozotocin diabetic rat.
    Bell ME; Eichberg J
    J Neurochem; 1985 Aug; 45(2):465-9. PubMed ID: 2989429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inositol and phospholipid metabolism in diabetic nerve.
    Eichberg J; Abe S; Berti-Mattera LN; Day NS; Lowery JM; Zhu X; Peterson RG
    Diabet Med; 1993; 10 Suppl 2():16S-20S. PubMed ID: 8392922
    [No Abstract]   [Full Text] [Related]  

  • 15. Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy.
    Dyck PJ; Zimmerman BR; Vilen TH; Minnerath SR; Karnes JL; Yao JK; Poduslo JF
    N Engl J Med; 1988 Sep; 319(9):542-8. PubMed ID: 3136330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hyperglycemia and its prevention by insulin treatment on the incorporation of 32P into polyphosphoinositides and other phospholipids in peripheral nerve of the streptozotocin diabetic rat.
    Berti-Mattera L; Peterson R; Bell M; Eichberg J
    J Neurochem; 1985 Dec; 45(6):1692-8. PubMed ID: 2997392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense.
    Obrosova IG; Van Huysen C; Fathallah L; Cao XC; Greene DA; Stevens MJ
    FASEB J; 2002 Jan; 16(1):123-5. PubMed ID: 11709499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of phosphoinositide metabolism, protein phosphorylation, and carbohydrate levels in sciatic nerve from Wistar fatty diabetic rats.
    Berti-Mattera LN; Lowery J; Day SF; Peterson RG; Eichberg J
    Diabetes; 1989 Mar; 38(3):373-8. PubMed ID: 2537246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats.
    Cameron NE; Cotter MA; Basso M; Hohman TC
    Diabetologia; 1997 Mar; 40(3):271-81. PubMed ID: 9084964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current aspects of research on the pathogenesis of diabetic neuropathy.
    Wuarin-Bierman L; Zahnd GR
    Diabete Metab; 1986 Dec; 12(6):319-24. PubMed ID: 3028879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.